Nico Straub, venture director at Siemens Technology Accelerator (STA), a corporate venturing subsidiary of industrial product and appliance producer Siemens, has joined venture capital management consulting firm Bioventure as a partner.
Founded in 2001, Germany-based Bioventure provides investment management services to life sciences and biotech-focused entrepreneurs and investors, helping the former pitch their ideas and raise funds, and the latter conduct due diligence and make equity investments.
As part of the deal, Straub is taking a board position at Bioventure customer Jennewein Biotechnologie, a Germany-based scarce functional sugars developer, through joint venture Bioventure Asset Management.
Straub had been at STA since 2013, overseeing startup investments and commercialising and licensing Siemens’ technologies. He became chairman of STA’s portfolio company Symeo, a developer of radar-empowered positioning systems for industrial automation, in 2016.
Symeo’s technology was first developed by Siemens and it was spun out as an independent company by STA in 2005, raising an undisclosed amount of seed funding in the process. He remained on its board until it was acquired by semiconductor maker Analog Devices in early 2018.
Photo of Nico Straub courtesy of LinkedIn.
